🕒 Wednesday 21 January 2026 Wed, 21 Jan 2026

Jindalee Lithium has reported robust assay results from its 2025 core drilling program at the McDermitt Lithium Project, highlighting significant near-surface lithium and magnesium mineralisation. These findings support ongoing metallurgical testwork and feasibility studies aimed at optimising project economics.

Australian Strategic Materials and Energy Fuels are set to discuss their proposed acquisition in a joint webcast, offering investors a closer look at this strategic move.

Pengana International Equities has raised its fully franked quarterly dividend to 1.4 cents per share, reflecting confidence in its earnings. Meanwhile, the company’s Independent Board Committee continues to evaluate strategic options, promising an update by February’s end.

Paladin Energy reports a 16% rise in uranium production at Langer Heinrich Mine, with strong sales and a fortified balance sheet positioning the company for growth. Exploration advances in Canada and leadership changes signal a strategic push forward.

Emerald Resources has announced a 27% increase in the Mineral Resource Estimate for its Memot Gold Project in Cambodia, now totaling 1.7 million ounces of gold, with full permitting in place to begin development this year.

Sovereign Metals has recovered a heavy rare earth monazite concentrate from its Kasiya project tailings, revealing concentrations of critical elements that surpass those of the world’s largest producers. This discovery could add a lucrative by-product stream at minimal cost, enhancing Kasiya’s strategic value amid tightening global supply chains.

OMG Group Limited has reported its first positive operating cashflow quarter, driven by a 63% year-on-year sales increase and expansion into premium Japanese matcha wholesale. This milestone signals a turning point in the company’s growth trajectory.

Westgold Resources has reported a record-breaking second quarter for FY26, with gold production surging 33% and underlying cash build doubling to $365 million, while maintaining a debt-free balance sheet.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.

St George Mining has extended its strategic alliance with US rare earths processor REalloys to finalise potential offtake agreements for high-grade rare earths from the Araxá Project in Brazil. This move aligns with US efforts to build independent rare earth supply chains critical for defence and green technologies.

Green & Gold Minerals reports outstanding high-grade gold drill results from Mt Wandoo and Little Wandoo, accelerating its development plans and expanding resource potential.

Energy Fuels Inc. has announced a proposed acquisition of Australian Strategic Materials (ASM) valued at approximately A$447 million, aiming to establish a leading Western rare earths and critical minerals producer with a fully integrated supply chain.

Energy Fuels Inc. has announced a binding agreement to acquire Australian Strategic Materials Ltd (ASM) in a deal valuing ASM at approximately A$447 million, offering shareholders a 121% premium. The acquisition aims to establish a vertically integrated Western rare earths supply chain, aligning with critical minerals strategies between the US and Australia.

White Cliff Minerals has revealed promising deep drilling results at its Danvers Copper Deposit in Nunavut, Canada, extending known copper mineralisation beyond previous limits and identifying new near-surface zones.

Barton Gold Holdings reports final Phase 1 drilling results from its Tunkillia Gold Project, revealing shallow, high-grade gold intersections that underpin a $1.3 billion operating profit forecast. The company is set to commence Phase 2 drilling and advance towards a Mining Lease application in 2026.

Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.

BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Astral Resources reports strong high-grade gold assay results from recent drilling at its Feysville and Mandilla projects in Western Australia, highlighting significant extensions beyond current resource models and advancing development prospects.

Vulcan Energy has reported strong production test results from its LSC-1b sidetrack well, reinforcing the viability of its Phase One Lionheart lithium project in Germany. The well’s performance supports the project’s ambitious lithium and renewable energy production targets.

Aurelia Metals reports a strong December quarter with production ramp-ups ahead of schedule at Federation Mine and robust progress across its Peak and Great Cobar projects, underpinning solid cash flow and a healthy balance sheet.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

Aurelia Metals has delivered robust metal production and cash flow in Q2 FY26, reaffirming its full-year guidance while advancing key growth projects on schedule.